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Abstract  
 
Purpose:  This study compared clinical outcomes and complications between 23-gauge (23g) and 25-
gauge (25g) transconjunctival sutureless vitrectomy in patients with proliferative diabetic 
retinopathy.  
 
Study design: This was a retrospective study using data prospectively defined and collected. 80 eyes 
underwent 23g transconjunctival sutureless vitrectomy, and 80 eyes underwent 25g surgery using 
the same vitrectomy system by one surgeon. Primary outcome measures were best-corrected visual 
acuity, intraocular pressure, and incidence of intraoperative and postoperative complications.  
 
Results: Vision was significantly improved after intervention in both groups (p=>0.0001). There was 
no significant difference in visual outcomes between the groups (p=0.43) or in the type and 
frequency of retinal breaks occurring during surgery (p=0.63). The 23g group had significantly more 
patients with a day one IOP of less than 6mmHg (p=0.034) and significantly more requiring a 
sclerostomy suture postopertively (p=0.014). 
 
Conclusion and Message: Both gauges are equally effective for the treatment of proliferative 
diabetic retinopathy.  
 
  
Introduction 
The first commercially available narrow gauge vitrectomy system was described by Fujii et al. in 2002 
[1]. Due to their perceived advantages increasing numbers of vitreo-retinal surgeons are now 
employing narrow gauge systems. These advantages include faster postoperative recovery with less 
postoperative discomfort, reduced surgically induced astigmatism and a quicker entry and exit from 
the eye [2,3]. Shortly after the first 25-gauge (25g) system was launched, 23-gauge (23g) systems 
became popular.  23g was rapidly adopted as it retained the fluid dynamics and instrumental rigidity 
offered by the 20-gauge (20g) systems and required minimal change in surgical technique. 
Subsequently 25g systems have been revised to make the instruments more rigid and with improved 
fluidics, which has resulted in an increased uptake for 25g. The Practice and Trends (PAT) survey of 
the American Society of Retina Specialists found that the percentage of surgeons who prefer small 
gauge surgery continues to increase. Over 90% of the 2013 survey participants stated that they most 
often employed small-gauge vitrectomy systems (either 23g or 25g), 20g vitrectomy was most 
often used by 3.7% to 7.2% of participants [4]. 
The utility of narrow gauge vitrectomy, both 25g and 23g, for a wide range of procedures has been 
demonstrated [6,7,8]. Numerous studies have favourably compared aspects of narrow gauge surgery 
to traditional sutured 20g surgery [9,10,11].  Studies have also found a reduction in peripheral 
retinal break formation near the sclerostomy sites with the cannulated sclersotomies used in narrow 
gauge systems [12,13]. 
Surprisingly little investigation has been carried out  into whether there are any differences in 
outcomes between 23g and 25g surgeries.  Although commonly grouped together there are multiple 
differences between 23g and 25g systems including sclerostomy size, instrument stiffness and utility, 
as well as fluidic capabilities and tissue attraction [3,14].  A comparison of small gauge systems is 
now of particular relevance given that 27-gauge (27g) systems are becoming available[15].  
This study focuses on a series of patients who were undergoing 23g and 25g vitrectomy for 
proliferative diabetic retinopathy (referred to as diabetic vitrectomy) by one surgeon over a three 
year period. In particular we analysed intraoperative and postoperative events to see if there were 
any differences in outcome between the two gauge sizes. 
 
Methods 
This is a retrospective, comparative, and consecutive record review conducted in the Sunderland Eye 
Infirmary. A consecutive series of patients who had undergone primary pars plana vitrectomy for the 
complications of proliferative diabetic retinopathy by one surgeon at Sunderland Eye Infirmary from 
January 2010 to March 2013 were prospectively identified, and data using predetermined 
definitions,  entered onto the surgeons own electronic database. For analysis the cases were divided 
into two groups: 
1) A group dating from January 2010 to September 2011 where only 23G vitrectomy surgery was 
carried out. 
2) A second group from October 2011 to March 2013 where only 25G vitrectomy surgery was carried 
out. 
A variety of pre, intra and postoperative characteristics for the patients were recorded, including 
age, sex, type and duration of diabetes. The amount of preoperative PRP administered was graded 
as equal to, or more than, ETDRS full scatter, less than standard ETDRS full scatter or no 
preoperative laser [16]. The extent and position of VR adhesion present was recorded as per Yorston 
et al  into none, disc attachment only, posterior pole attachment only or 1-4 quadrants of anterior 
vitreo-retinal attachment [17]. Patients were followed up at 1 day, two weeks, and six months 
postoperatively as a minimum and as needed according to the clinical circumstances. 
All surgeries were carried out using the Alcon Constellation 23 and 25g + systems (Alcon, Forth 
Worth, USA).  A wide-angle non-contact indirect viewing system, with an in-built image inverter, was 
used in all cases. The Edge plus one step entry system was used in all cases and the technique was 
common to both gauges. After conjunctival displacement, acutely oblique entry into the sclera was 
made with the trochar and continued until the sclerostomy cannula abutted the sclera. The trochar 
was then moved to 30 degrees to the globe and final entry made. 
Core vitrectomy was carried out using a cut rate of 5000 cuts per minutes (CPM) with proportional 
vacuum settings and a maximum vacuum of 350mmHg for 23g and 550mmHg for 25g. Intraocular 
pressure was set at 26mmHg with the IOP compensation system activated for both groups with 
intermittent raised pressure for haemostasis as required. After core vitrectomy, delamination and 
removal of all posterior hyaloid face and fibro-vascular membrane was carried out. This was carried 
out primarily with the vitreous cutter alone and intra-vitreal scissors only if necessary. When 
performing cutter delamination a 3D mode was used with a biased closed duty cycle, and a cut rate 
of 3000 CPM declining to 1500 CPM as previously described [18]. In no cases was a sclerotomy 
opened up for 20 gauge instruments. Careful inspection to detect the presence of vitreo-schisis was 
made and staining of residual vitreous gel using diluted triamcinolone was used routinely in all cases. 
Any vitreoschisis detected was peeled using the vitreous cutter and forceps as necessary. Peripheral 
vitreous was removed, especially around the inner sclerotomy wounds, with deep scleral 
indentation.  
Endolaser retinal laser photocoagulation was carried out to complete any deficiencies in previous 
laser and was also carried out up to the ora serrata in all eyes. An internal search using endo-viewing 
and indentation with a non-contact wide field viewing system was performed. Retinal breaks were 
treated with argon laser retinopexy or cryotherapy. Breaks were classified as being either posterior 
and usually related to dissection or surgical traction or peripheral related to vitreous separation- 
these were further divided into entry site related occurring with one clock hour either side of the 
sclerostomies or other vitreous separation related breaks.  Silicone oil, Sulfur hexafluoride (SF6) gas 
or air were used as postoperative tamponade where needed. Preoperative anti VEGF therapy was 
used in selected patients relating to the activity and extent of the neovasculariation. Combined 
phacovitrectomy was carried out in cases with visually significant cataract obscuring the operative 
view.  
At the end of surgery, and after sclerostomy guard removal sclerostomy closure was checked by 
inflating the eye to a pressure of 30mmHg using a 30g needle inserted through the pars plana 
connected to an airline.   If any sclerostomy leak was present an 8/0 absorbable suture was used to 
secure the wound. 
 
Postoperative vitreous cavity clarity was recorded on a 4 point scale from 0-3 with 0 being 
completely clear to 3 being a dense haemorrhage with no red reflex visible as used previously [19]. 
Any postoperative vitreous cavity haemorrhage was categorised as early (present on first 
postoperative day or occurring within the first postoperative 3 week period) or late (occurring 
greater than 3 weeks postoperatively). 
Eyes with previous vitrectomy surgery were excluded from the study.  One patient in the 23g group 
and two in the 25g group had silicone oil used and these were excluded from further analysis but are 
presented in Table 5. 
The groups were compared using Minitab 16 (Minitab Ltd, Coventry, UK) for statistical analysis. Case 
characteristics were calculated using descriptive statistics, including mean and SD. Categorical 
variables were compared using Fisher’s exact test and Pearson’s χ2-test as appropriate. Means were 
compared using Student’s t-test for unequal variance. P-values of <0.05 were considered statistically 
significant. Snellen chart measurements were converted to logarithmic minimum angle of resolution, 
LogMAR, for statistical analysis. Acuity values were assigned to counting fingers and hand motion as 
recommended by Holladay [20]. 
Results 
During the study period there were 80 eyes of 78 patients who had 23 gauge vitrectomy and 80 eyes 
of 79 patents that had 25 gauge vitrectomy for complications related to proliferative diabetic 
retinopathy. Eyes with previous vitrectomy surgery were excluded (0) as were eyes which required 
silicone oil (3).   
The groups were well matched with a mean age of approximately 52 years old. In particular the 
duration of diabetes, HbA1c and the use of blood thinning agents preoperatively did not differ 
significantly. The groups were also similar in terms of their indications for surgery and complexity in 
terms of the extent of vitreoretinal attachment present (Table 1). 
Six month follow up was achieved in 96% and 97% of the 23g and 25g groups respectively. Both 
groups had significantly improved vision at 6 months (p=>0.0001) but there were no significant 
differences between visual acuities at any of the time points recorded (Table 2).Similarly the 
frequency of cataract surgery following vitrectomy was equivalent.  
Eighteen (23%) eyes in the 23g group required at least one sclerostomy suture compared to only 6 
(8%) eyes in the 25g group. (p=0.014). There was no significant difference between mean day 1 and 
day 14 IOPs but there were significantly more patients with a day one IOP of less than 6mmHg in the 
23g group( p=0.034) (Table 2).  
Scissors were necessary in 6 patients in the 23g group and 3 patients in the 25g group (p=0.49). 
There was no significant difference in the type and frequency of retinal breaks between the two 
groups (Table3). There was one case of postoperative retinal detachment in the 23g group and none 
in the 25g group (Table 3). 
There were no significant differences between the day 1 and day 14 vitreous cavity clarity secondary 
to haemorrhage between the groups or rate of occurrence of early and late postoperative vitreous 
cavity haemorrhage (Table 2). 
Table 4 details adverse outcomes which were encountered during the study and Table 5 discusses 
the excluded eyes which required silicon oil. 
 
Discussion 
This study sought to compare surgical outcomes for 25g and 23g vitrectomy surgery for diabetic 
vitrectomy. We choose diabetic vitrectomy because of the well-known side effect and complication 
profile.  The 160 surgeries analysed were carried out over a three year period by a single surgeon.  
Our 23g and 25g cohorts were both well matched, with none of baseline variables recorded differing 
significantly between the groups. Importantly the surgical complexity was well matched with no 
significant difference in the extent of vitreoretinal adhesion between the two groups.    
 
Visual improvement and rates of surgical complications were broadly similar between the groups. 
The only outcomes which reached significance were the increased frequency of sclerostomy suture 
and postoperative hypotony in the 23g.The two groups used the same entry system design and 
oblique entry technique and the difference must relate to the size of the sclerostomy. At the 
conclusion of surgery all eyes, even if not requiring tamponade had a partial fluid air exchange and 
then had the eye inflated to a pressure of 30mmHg with a 30g needle. More 23g sclerostomies 
required suturing based on this protocol. Despite this there was still a higher hypotony rate in the 
23g group on the first day. Transient hypotony (IOP <6) one day postoperatively occurred in 10% of 
23G and 2% of 25g surgeries in out cohort, this was a significant difference (p=0.034).  Transient 
hypotony of 23g has been noted by several other studies.  Park et al, found 0% (66/101) of their  20g 
and 22% (45/101) of their  23g group to be under <8mmhg, at day 1 postoperatively [21]. Both Akçay 
al. and  Lotte et al similarly found high rates of transient hypotony in 23G studies; 9.8% (34/350) and 
10% (10/100) of eyes treated with 23g had 1 day post op IOP of <6 [22,23].   
It is well recognised that 20 gauge surgery carries less risk of day one hypotony. Framme et al 
studied IOP post 20g surgery and found that transient low IOP was infrequent at 1.2% (10/851) eyes 
(24). IOP post 25g surgery has been less frequently investigated, Gupta et al. found a rate similar to 
our study of 5.7% (4/75) [25].  
A feared consequence of day 1 hypotony is intraocular haemorrhage and with the larger 
sclerostomies. Therefore  we may have expected to have found an increased incidence of day 1 
vitreous cavity haemorrhage in the 23g on account of the higher rate of day 1 hypotony in this 
group.  This however was not found; both groups had similar rates of POVCH both early and late. 
This could be due to the sample size being too small to detect any difference.  
 
Previous studies into small gauge surgery for diabetic vitrectomy have compared rates of POVCH 
between 20g and 23g systems, or evaluated a specific gauge independently. POVCH has been 
reported as being more frequent with larger gauge instruments. Yang et al recorded a one month re-
bleed rate of 18% in 20g and 7% in 25g [26].  Farnouk et al reported a rate of 11% series of 200 25g 
operations [27].  Our study did not find there to be any marked difference in re-bleed rates between 
23g and 25g at any time period. The total number of patients requiring further surgery for POVCH 
was 9% in the 23g group and 6% in the 25g group (p=0.77). These results are similar to the 10.4% 
reoperation rate found by Schoenberger et al. in series of 174 25g operations [28].  
  
A reported benefit of transconjunctival small gauge surgery over 20g is faster visual recovery [12,13]. 
This study did not find that this trend continues when comparing 23g to 25g. We found no significant 
difference in the speed of visual recovery between the groups using the 14 day and 6 month time 
points as a guide.   
 
The settings used for core vitrectomy between the two gauges actually result in very similar 
achievable  flow rates in vitreous and we did not note any clinically relevant difference in the 
duration of surgery between the groups although did not record this systematically. However as 
gauge size reduces the sphere of influence of fluid flow around the port reduces [14]. The effect of 
the vitrectomy probe induced fluid flow is therefore more localised in smaller gauges meaning that it 
exert less traction on distant tissue and with the smaller port size is more exact when carrying out 
cutter dissection. This may mean that scissor use will less often be required and that the iatrogenic 
break rate may reduce with smaller gauge. We did not find this however between 23g and 25g. 
Several papers have reported that significantly fewer peripheral retinal breaks are caused by 
cannulated  23g systems compared to the 20g [12,13,29],. Our entry site break rate was very low in 
both groups at 1 eye in each group as may have been expected as the cannulated sclerostomy 
system is identical in length in each gauge at 6mm.The use of scissors was marginally greater in the 
23g group and there was a non-significant higher number of posterior iatrogenic breaks and other 
posterior vitreous detachment related breaks and it may be that larger studies would show a 
difference. It will be of great interest to contrast our reported rates of peripheral retinal breaks and 
other complications with the upcoming 27g system to see if any significant advantage can be 
accrued by having a yet smaller gauge system. There was only one cases of postoperative 
detachment in the study and underlies the importance of break detection and treatment for 
detachment prevention.  
 
There has been a long running debate over a possible higher rate of endophthalmitis in 
transconjunctival narrow gauge surgery compared to sutured 20g surgery.  Earlier research found 
that rates were increased in smaller gauge surgery [30]. However more recent and larger studies 
have found no significant difference in the rate of endophthalmitis with smaller gauge surgery 
[31,32]. It is likely that these differing conclusions reflect the evolution of small gauge surgery; 
improving surgical technique and advancing technology have perhaps resulted in a falling incidence 
of endophthalmitis. We had no cases of endophthalmitis in either group but the incidence of this 
complication is very low and substantially larger studies would be needed to investigate this further.  
 This study has several strengths. It is the largest direct comparison between of 23g and 25g surgical 
outcomes for diabetic vitrectomy, with all operations were carried out by a single surgeon. Every 
new surgical system has a learning curve but the surgeon had been using both 23g and 25g surgery 
for several years before the data was gathered. Both groups in the study were well matched 
medically and demographically. Lastly its findings are in keeping with previous works which looked 
at 25g and 23g gauge systems in isolation.  
It does however also have several weaknesses. Firstly, as with many vitreoretinal studies there is 
insufficient power to facilitate comment on rarer outcomes such as rates of endophthalmitis. 
Secondly, due to the retrospective, chronological nature of the study patients could not randomised 
between groups. Lastly, it could be argued that as the surgeon progressed to using the 25g 
instruments his operative skill would have also progressed, however he had already been using 25g 
for 5 years for other conditions so this effect was unlikely to be significant. It is possible however 
that a surgeon unfamiliar with 25g may have achieved different results. It is also possible that with 
an alternative surgical system, different results between the gauges may have been found.  
 
The fundamental finding of this investigation is that both 23g and 25g systems are highly effective 
for treating proliferative diabetic retinopathy. Advocates of the individual gauges have argued the 
advantages of both with the perceived advantages of 23g over 25g being its similar instrument 
handling  to 20g and the advantages of 25g being its fluidic behaviour  and smaller sclerostomy size.   
Our study shows that both can achieve good visual outcomes with a similar and low rate of post-
operative complications. Our study did however indicate that operations conducted with the 25g 
system were less likely to induce transient hypotony or require a sclerostomy suture.  
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